Company profile for Guangzhou Novaken Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2007, NOVAKEN, is a pharmaceutical company located in Guangzhou. The company focuses on drug R&D, CRO services, and outcome transformation. It has developed six major technology platforms for drug-sustained controlled release, insoluble drugs, gel release, microsphere industrialization, microneedles, and pulmonary drug delivery. The company's pharmaceutical preparations focus on new drug formulations and drug delive...
Founded in 2007, NOVAKEN, is a pharmaceutical company located in Guangzhou. The company focuses on drug R&D, CRO services, and outcome transformation. It has developed six major technology platforms for drug-sustained controlled release, insoluble drugs, gel release, microsphere industrialization, microneedles, and pulmonary drug delivery. The company's pharmaceutical preparations focus on new drug formulations and drug delivery systems, enabling patients to recover from the disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Health Industry Incubation Base, 280 East Circle, University Town, Guangzhou 5...
Telephone
Telephone
+86 02031136969
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Drugs in Development

read-more
read-more

Details:

Dexmedetomidine HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Sedation.


Lead Product(s): Dexmedetomidine Hydrochloride

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 11, 2025

blank

01

BIO Partnering at JPM
Not Confirmed
BIO Partnering at JPM
Not Confirmed

Details : Dexmedetomidine HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Sedation.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 11, 2025

blank

Details:

XJN010 is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Parkinson Disease.


Lead Product(s): XJN010

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 05, 2025

blank

02

BIO Partnering at JPM
Not Confirmed
BIO Partnering at JPM
Not Confirmed

Details : XJN010 is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Parkinson Disease.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 05, 2025

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : ESOMEPRAZOLE MAGNESI...

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : ESOMEPRAZOLE MAGNESI...

arrow
BIO Partnering at JPM
Not Confirmed

Guangzhou Novaken Pharmaceutical

Dosage Form : CAPSULE, DELAYED REL PEL...

Brand Name : ESOMEPRAZOLE MAGNESIUM

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2020-11-18

Application Number : 213859

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : ESOMEPRAZOLE MAGNESI...

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : ESOMEPRAZOLE MAGNESI...

arrow
BIO Partnering at JPM
Not Confirmed

Guangzhou Novaken Pharmaceutical

Dosage Form : CAPSULE, DELAYED REL PEL...

Brand Name : ESOMEPRAZOLE MAGNESIUM

Dosage Strength : EQ 40MG BASE

Packaging :

Approval Date : 2020-11-18

Application Number : 213859

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : POTASSIUM CHLORIDE

Biotech Showcase
Not Confirmed
arrow

Brand Name : POTASSIUM CHLORIDE

arrow
Biotech Showcase
Not Confirmed

Guangzhou Novaken Pharmaceutical

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : POTASSIUM CHLORIDE

Dosage Strength : 10MEQ

Packaging :

Approval Date : 2021-01-28

Application Number : 214395

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : POTASSIUM CHLORIDE

Biotech Showcase
Not Confirmed
arrow

Brand Name : POTASSIUM CHLORIDE

arrow
Biotech Showcase
Not Confirmed

Guangzhou Novaken Pharmaceutical

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : POTASSIUM CHLORIDE

Dosage Strength : 20MEQ

Packaging :

Approval Date : 2021-01-28

Application Number : 214395

Regulatory Info : RX

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty